Evidence map›Paper›PMID 35831116›Full record

ReviewInternal medicine (Tokyo, Japan)2023

Lung and Cerebral Nocardiosis Caused by Nocardia elegans in a Lung Transplant Recipient: A Case Report and Literature Review.

Keitaro Omori, Hiroki Kitagawa, Rie Nagaoka, Yasuhiko Naka, Kazuma Kawamoto, Yasushi Horimasu, Toshihito Nomura, Norifumi Shigemoto, Takashi Yaguchi, Noboru Hattori and 1 more

Open access · diamondAbstract readReviewCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Review in Internal medicine (Tokyo, Japan), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Pulmonary nocardiosis followingFrontiers in medicine · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Keitaro OmoriDepartment of Infectious Diseases, Hiroshima University Hospital, Japan.
Hiroki KitagawaDepartment of Infectious Diseases, Hiroshima University Hospital, Japan.
Rie NagaokaSection of Clinical Laboratory, Department of Clinical Support, Hiroshima University Hospital, Japan.
Yasuhiko NakaDepartment of Molecular and Internal Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan.
Kazuma KawamotoDepartment of Molecular and Internal Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan.
Yasushi HorimasuDepartment of Molecular and Internal Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan.
Toshihito NomuraDepartment of Infectious Diseases, Hiroshima University Hospital, Japan.
Norifumi ShigemotoDepartment of Infectious Diseases, Hiroshima University Hospital, Japan.
Takashi YaguchiMedical Mycology Research Center, Chiba University, Japan.
Noboru HattoriDepartment of Molecular and Internal Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan.
Hiroki OhgeDepartment of Infectious Diseases, Hiroshima University Hospital, Japan.
Hiroshima University · JPHiroshima University Hospital · JPChiba University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients after lung transplantation are at risk for Nocardia infections. We herein report a case of lung and cerebral nocardiosis caused by Nocardia elegans, a rare species of Nocardia, in a lung transplant recipient. Antibiotic therapy, including sulfamethoxazole-trimethoprim (ST), and brain abscess drainage improved symptoms and imaging findings. A literature review of N. elegans infections showed that 12 of 14 cases (85.7%) were reported from East Asia, particularly Japan (9 cases, 64.2%). The lungs were the predominant site (12/14 cases, 85.7%), and most of the cases were susceptible to ST (9/10 cases, 90%).

Indexed as

Lung TransplantationNocardiaNocardia InfectionsAnti-Bacterial AgentsHumansLungTransplant RecipientsTrimethoprim, Sulfamethoxazole Drug CombinationAnti-Bacterial AgentsTrimethoprim, Sulfamethoxazole Drug Combinationbrain abscesslung and cerebral nocardiosislung transplantmass spectrometryNocardia elegans

Identifiers

PMID35831116
PMCPMC9970818
OpenAlexW4285413866

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.